24 September 2025
Nearly 45 participants from the OHIO department gathered for a morning of fun and conviviality.
news from the crcm
24 September 2025
Anne-Sophie Chrétien, Frédéric Bard and Brice Chanez - all three recipients of specific "Pancreatic Cancer" funding from the ARC Foundation -.
19 June 2025
Our latest article, in collaboration with Helle Ulrich, explores how the timing of lesion […]
11 April 2025
The Centre de Recherche en Cancérologie de Marseille (CRCM) brings together a dynamic community of scientists, clinicians and technical staff committed to the fight against cancer.
20 February 2025
The team has just received pre-maturation funding from Cancéropôle PACA for its project to validate a biomarker predictive of the eligibility of patients with acute myeloid leukemia (AML) for treatment with menin inhibitors.
10 February 2025
We are delighted to welcome Josephine Shabani, a Master 2 student at the University of Verona (Italy), who has recently joined our team.
10 February 2025
This publication in Cell reveals how two distinct E3 ligases target BACH1 quaternary degrons under oxidative stress, in collaboration with several research teams.
28 January 2025
The "Control of structure-specific endonucleases and genome stability" team (Gaillard team) is proud to receive support from the Ligue Nationale Contre le Cancer.
28 January 2025
HU LUCA-pi on lung cancer prevention, PEPR Santé Numérique DIGPHAT for pharmacology modeling and the SouthRock consortium, an alliance with the CRCL to combat pediatric cancers.
28 January 2025
Welcome to Elias Ventre and Quentin Marcou, who join the COMPO team, headed by Drs Benzekry and Ciccolini, as Research Associates.
28 January 2025
Thanks to the Pancreas-View tool, personalized treatment for pancreatic cancer is becoming a reality. By integrating artificial intelligence and molecular signatures, this tool promises to improve treatment efficacy and patient survival.
28 January 2025
Pancreatic cancer, one of the most aggressive cancers, is at the heart of the COMBAT-PDAC project, supported by Europe and the ANR. The aim is to personalize treatments using innovative models and identify biomarkers to improve patient survival.